MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.78 +0.15 (+0.15%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
News headline image
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
From Exact Sciences Corp.
Via Business Wire
News headline image
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? ↗
The company reported lighter-than-expected third-quarter sales due to issues with physician order rates. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point ↗
Exact Sciences Q3 EPS loss of $0.21 fell short of analyst expectations. 2024 revenue guidance lowered amid screening segment hurdles, growth plans set for 2025. 
Via Benzinga
News headline image
Will EXACT SCIENCES CORP breakout? ↗
With a solid technical rating of 8 out of 10, EXACT SCIENCES CORP (NASDAQ:EXAS) is showing strong indications of a possible breakout. 
Via Chartmill
News headline image
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings) ↗
 
Via Benzinga
News headline image
(EXAS) - Analyzing Exact Sciences's Short Interest ↗
 
Via Benzinga
News headline image
Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript ↗
EXAS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Analyst Ratings For Exact Sciences ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For Exact Sciences ↗
 
Via Benzinga
News headline image
Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates ↗
Exact Sciences shares are dropping after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the details. 
Via Benzinga
News headline image
Exact Sciences Announces Third-Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
News headline image
Exact Sciences to Participate in November Investor Conference
From Exact Sciences Corp.
Via Business Wire
News headline image
Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
From Exact Sciences Corp.
Via Business Wire
News headline image
Can This Beaten-Down Cathie Wood Stock Bounce Back? ↗
An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a comeback. 
Via The Motley Fool
News headline image
Exact Sciences Schedules Third Quarter 2024 Earnings Call
From Exact Sciences Corp.
Via Business Wire
News headline image
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test ↗
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in... 
Via Benzinga
News headline image
Exact Sciences Stock Rises After FDA Signs Off On New Cologuard ↗
The company is soon to launch its next-generation colon cancer screening tool. 
Via Investor's Business Daily
News headline image
FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening
From Exact Sciences Corp.
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
From Exact Sciences Corp.
Via Business Wire
News headline image
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings. 
Via Benzinga
News headline image
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Exact Sciences to Participate in September Investor Conferences
From Exact Sciences Corp.
Via Business Wire
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Via AB Newswire
News headline image
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) 
Via News Direct
News headline image
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
From Exact Sciences Corp.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story